Jameel Mohsen

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes—A multicenter registry

Alexander Fardman, Doron Zahger, Katia Orvin et al. · PLoS ONE · 2021 · 59 citations · Full text

Medicine, Cardiology, Internal Medicine +11

Direct Admission of Patients With ST‐Segment–Elevation Myocardial Infarction to the Catheterization Laboratory Shortens Pain‐to‐Balloon and Door‐to‐Balloon Time Intervals but Only the Pain‐to‐Balloon Interval Impacts Short‐ and Long‐Term Mortality

Simcha Meisel, Michael Kleiner‐Shochat, Rami Abu‐Fanne et al. · Journal of the American Heart Association · 2020 · 35 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Differentiation between myopericarditis and acute myocardial infarction on presentation in the emergency department using the admission C-reactive protein to troponin ratio

Simcha Meisel, Rami Abu Fanne, Majdi Saada et al. · PLoS ONE · 2021 · 12 citations · Full text

Medicine, Emergency Medicine, Internal Medicine +13